Skip to Main Content

A version of this story also appeared in D.C. Diagnosis, STAT’s weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox.

WASHINGTON — The Canadian government reassured pharmaceutical industry representatives that “all options are on the table” regarding the Trump administration’s plan to import drugs from Canada at a closed-door briefing last week, according to an attendee.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!